{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:13:52Z","timestamp":1793060032541,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18fk0210034"],"award-info":[{"award-number":["JP18fk0210034"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18fk0210043"],"award-info":[{"award-number":["JP18fk0210043"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012319","name":"National Center for Global Health and Medicine","doi-asserted-by":"publisher","award":["27-1302"],"award-info":[{"award-number":["27-1302"]}],"id":[{"id":"10.13039\/100012319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.cyto.2019.154816","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T12:01:46Z","timestamp":1566820906000},"page":"154816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["IFN-\u03bb3 as a host immune response in acute hepatitis E virus infection"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3419-6297","authenticated-orcid":false,"given":"Kazumoto","family":"Murata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Hon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyasu","family":"Karino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomofumi","family":"Atarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Oohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Uebayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekatsu","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Matsubayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Mishiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Mizokami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0827-0964","authenticated-orcid":false,"given":"Hiroaki","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2019.154816_b0005","doi-asserted-by":"crossref","unstructured":"N. Kamar, R. Bendall, F. Legrand-Abravanel F, et al., Hepatitis E, Lancet 379 (2012) 2477-2488. doi: 10.1016\/S0140-6736(11)61849-7.","DOI":"10.1016\/S0140-6736(11)61849-7"},{"key":"10.1016\/j.cyto.2019.154816_b0010","unstructured":"World Health Organization. Hepatitis E: Fact Sheet <https:\/\/www.who.int\/mediacentre\/factsheets\/fs280\/en\/>."},{"key":"10.1016\/j.cyto.2019.154816_b0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/hepr.12175","article-title":"Features of hepatitis E virus infection in humans and animals in Japan","volume":"44","author":"Takahashi","year":"2014","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.cyto.2019.154816_b0020","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM200210313471819","article-title":"Fulminant hepatitis E in Japan","volume":"347","author":"Suzuki","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2019.154816_b0025","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/jmv.2031","article-title":"Genetic heterogeneity of hepatitis E virus","volume":"65","author":"Schlauder","year":"2001","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cyto.2019.154816_b0030","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/hep.24674","article-title":"Hepatitis E","volume":"54","author":"Aggarwal","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2019.154816_b0035","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0140-6736(03)14025-1","article-title":"Zoonotic transmission of hepatitis E virus from deer to human beings","volume":"362","author":"Tei","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2019.154816_b0040","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients","volume":"358","author":"Kamar","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2019.154816_b0045","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.ebiom.2015.09.030","article-title":"A nationwide survey of hepatitis E virus infection and chronic hepatitis E in liver transplant recipients in Japan","volume":"2","author":"Inagaki","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cyto.2019.154816_b0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-\u03bbs mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2019.154816_b0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","author":"Sheppard","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2019.154816_b0060","doi-asserted-by":"crossref","first-page":"7944","DOI":"10.1073\/pnas.1100552108","article-title":"IFN-\u03bb determines the intestinal epithelial antiviral host defense","volume":"108","author":"Pott","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2019.154816_b0065","doi-asserted-by":"crossref","first-page":"e1000017","DOI":"10.1371\/journal.ppat.1000017","article-title":"IFN-lambda (IFN-\u03bb) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo","volume":"4","author":"Sommereyns","year":"2008","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.cyto.2019.154816_b0070","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1128\/AAC.02427-15","article-title":"Antiviral activities of different interferon types and subtypes against hepatitis E virus replication","volume":"60","author":"Todt","year":"2016","journal-title":"Antimicrob. Agents. Chemother."},{"key":"10.1016\/j.cyto.2019.154816_b0075","doi-asserted-by":"crossref","first-page":"e1006417","DOI":"10.1371\/journal.ppat.1006417","article-title":"Hepatitis E virus persists in the presence of a type III interferon response","volume":"13","author":"Yin","year":"2017","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.cyto.2019.154816_b0080","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s00535-014-1023-2","article-title":"Association of serum IFN-\u03bb3 with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection","volume":"50","author":"Aoki","year":"2015","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.cyto.2019.154816_b0085","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1872-034X.2012.01032.x","article-title":"Development of specific and qualitative real-time detection PCR and immunoassay for IFN-\u03bb3-interferon","volume":"42","author":"Sugiyama","year":"2012","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.cyto.2019.154816_b0090","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1872-034X.2011.00860.x","article-title":"Diagnostic criteria of acute liver failure: a report by the intractable hepato-biliary diseases study group of Japan","volume":"41","author":"Mochida","year":"2011","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.cyto.2019.154816_b0095","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1099\/vir.0.066910-0","article-title":"Hepatitis E virus egress depends on the exosomal pathway, with secretory exosomes derived from multivesicular bodies","volume":"95","author":"Nagashima","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.cyto.2019.154816_b0100","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1128\/JCM.00629-09","article-title":"Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HE-JF5\/15F strain recovered from a fulminant hepatitis patient","volume":"47","author":"Tanaka","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.cyto.2019.154816_b0105","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1086\/340023","article-title":"Genetic heterogeneity of hepatitis E virus recovered from Japanese patients with acute sporadic hepatitis","volume":"185","author":"Takahashi","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cyto.2019.154816_b0110","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/j.1537-2995.2008.01722.x","article-title":"A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route","volume":"48","author":"Matsubayashi","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.cyto.2019.154816_b0115","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1128\/JCM.40.9.3209-3218.2002","article-title":"Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan","volume":"40","author":"Mizuo","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.cyto.2019.154816_b0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00535-012-0682-0","article-title":"Culture systems for hepatitis E virus","volume":"48","author":"Okamoto","year":"2013","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.cyto.2019.154816_b0125","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/gutjnl-2016-312653","article-title":"Induction of IFN-\u03bb3 as an additional effect of nucleoside, not nucleotide, analogues: a new potential target for HBV infection","volume":"67","author":"Murata","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.cyto.2019.154816_b0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.1258100","article-title":"Interferon-\u03bb cures persistent murine norovirus infection in the absence of adaptive immunity","volume":"347","author":"Nice","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cyto.2019.154816_b0135","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/jvh.12491","article-title":"Disparity of basal and therapeutically activated interferon signaling in constraining hepatitis E virus infection","volume":"23","author":"Zhou","year":"2016","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.cyto.2019.154816_b0140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.immuni.2014.12.016","article-title":"The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus","volume":"42","author":"Sato","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2019.154816_b0145","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.gastro.2011.12.055","article-title":"HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons","volume":"142","author":"Thomas","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2019.154816_b0150","doi-asserted-by":"crossref","first-page":"11924","DOI":"10.1128\/JVI.01935-14","article-title":"Hepatitis E virus inhibit type I interferon induction by ORF1 products","volume":"88","author":"Nan","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2019.154816_b0155","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.284.5415.825","article-title":"Viral clearance without destruction of infected cells during acute HBV infection","volume":"284","author":"Guidotti","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.cyto.2019.154816_b0160","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1002\/hep.29702","article-title":"The RNA genome of hepatitis E virus robustly triggers an antiviral interferon response","volume":"67","author":"Wang","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2019.154816_b0165","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3389\/fimmu.2017.00621","article-title":"Peg-interferon lambda treatment induces robust innate and adaptive immunity in chronic hepatitis B patients","volume":"8","author":"Phillips","year":"2017","journal-title":"Front. Immunol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466619302455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466619302455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:55:46Z","timestamp":1760907346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466619302455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":33,"alternative-id":["S1043466619302455"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2019.154816","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IFN-\u03bb3 as a host immune response in acute hepatitis E virus infection","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2019.154816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154816"}}